March 23: Coronavirus Update and Portfolio Guidance

March 23, 2020 | Greg Leonberger, FSA, EA, MAAA, Director of Research, Managing Partner

The following newsletter presents our most recent guidance on the coronavirus pandemic, stimulus measures enacted across the globe, and asset class summaries. This is an extremely fluid environment with markets changing by the minute; we will continue to update clients as the week progresses. All of the data cited in this update is as of March 20th unless otherwise noted.

Read > March 23: Coronavirus Update and Portfolio Guidance

As always, please reach out to your consultant or our research team for more details about any of the information presented in this update. For more Marquette coverage on COVID-19, please view the Coronavirus Updates topic on our Research page.

 

The opinions expressed herein are those of Marquette Associates, Inc. (“Marquette”), and are subject to change without notice. This material is not financial advice or an offer to purchase or sell any product. Marquette reserves the right to modify its current investment strategies and techniques based on changing market dynamics or client needs.

Greg Leonberger, FSA, EA, MAAA
Director of Research, Managing Partner

Get to Know Greg

Related Content

06.29.2020

Sustainable Investing in a Post-COVID World

Defined as an unpredictable occurrence that is beyond the scope of normal expectations, a black swan event is rare and…

06.09.2020

The Impact of COVID-19 on Not-for-Profit Healthcare Systems

The onset of the global pandemic caused by COVID-19 has created substantial stress in the financial markets and the broader…

06.03.2020

Bank Loans vs. High Yield: Is One Safer Than the Other?

Year-to-date, bank loans and high yield bonds have been subject to a variety of market forces similar between the two…

06.01.2020

Don’t Mind the Gap

On the surface it looks disjointed. We are in the midst of what is likely the worst recession since the…

05.22.2020

Brighter Lights at the End of a Shorter Tunnel

Biotech company Moderna’s announcement earlier this week that its coronavirus vaccine successfully helped healthy adults produce antibodies against COVID-19 sent…

05.11.2020

Is It Game Over for Value Stocks?

Over the last ten years, growth stocks have outperformed value stocks by an average 5.3% per year, and the differential…

More articles

Subscribe to Research Email Alerts

Research Email Alert Subscription

Research alerts keep you updated on our latest research publications. Simply enter your contact information, choose the research alerts you would like to receive and click Subscribe. Alerts will be sent as research is published.

We respect your privacy. We will never share or sell your information.

Thank You

We appreciate your interest in Marquette Associates.

If you have questions or need further information, please contact us directly and we will respond to your inquiry within 24 hours.

Contact Us >